Review of Current Issues in Pharmaceutical Excipients - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Review of Current Issues in Pharmaceutical Excipients
Excipients facilitate formulation design and perform a wide range of functions to obtain desired properties for the finished drug product. The article reviews excipient development and functionality of these materials, including their importance in formulation design, potential processing challenges directly related to excipients, and therapeutic benefits.

Pharmaceutical Technology

16. P.J. Weller, "Ceratonia," in Handbook of Pharmaceutical Excipients, R.C. Rowe, P.J. Sheskey, and P.J. Weller, Eds. (Pharmaceutical Press and American Pharmaceutical Association, Chicago, IL, 2003), pp. 123–124.

17. B. Wittgren, M. Stefansson, and B. Porsch, "Interactions between Sodium Dodecyl Sulphate and Non-Ionic Cellulose Derivatives Studies by Size Exclusion Chromatography with Online Multiangle Light Scattering and Refractometric Detection," J. Chromatogr. A. 1082 (2), 166–175 (2005).

18. J.A. Menendez et al., "A Genomic Explanation Connecting Mediterranean Diet, Olive Oil, and Cancer: Oleic Acid, the Main Monounsaturated Fatty Acid of Olive Oil, Induces Formation of Inhibitory PEA3 Transcription Factor-PEA3 DNA Binding Site Complexes at Her-2/neu (erbB-2) Oncogene Promoter in Breast, Ovarian, and Stomach Cancer Cells," Eur. J. Cancer (Jan. 4, 2006).

19. J.A. Menendez et al., "Effect of Gamma-Linolenic Acid on the Transcriptional Activity of the Her-2/neu (erbB-2) Oncogene," J. Natl. Cancer Inst. 97 (21), 1611–1615 (2005).

20. J.A. Menendez, R. Lupu, and R. Colomer, "Targeting Fatty Acid Synthase: Potential for Therapeutic Intervention in Her-2/neu-OverExpressing Breast Cancer," Drug News Perspect. Jul.-Aug, 18 (6), 375-85 (2005)

21. M. Uhari, T. Kontiokari, and M. Niemela, "A Novel Use of Xylitol Sugar in Preventing Acute Otitis Media," Pediatrics 102 (4), 879–884 (1998).

22. "FDA Issues Glucose Meter Safety Warning," DOC News 3 (1), 7,, accessed April 1, 2007.

23. A.M. Cattelan et al., "Use of Polylactic Acid Implants to Correct Facial Lipoatrophy in Human Immunodeficiency Virus 1-Positive Individuals Receiving Combination Antiretroviral Therapy," Arch Dermatol. 142 (3), 362–364 (2006).

24. T. Gyotoku, L. Aurelian, and A.R. Neurath, "Cellulose Acetate Phthalate (CAP): An 'Inactive' Pharmaceutical Excipient with Antiviral Activity in the Mouse Model of Genital Herpesvirus Infection," Antiviral Chem. Chemotherapy 10, 327–332 (1999).



27. J. Morton, "Taking the Color of Medications Seriously,", accessed April 1, 2007.

28. Capsugel List of Colorants for Oral Drugs, 11th ed. (Pfizer Inc. Capsugel Division, 2002).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here